Optimizing hyperbaric oxygen initiation time in carbon monoxide poisoning: a 3-hour window enhances neurological recovery via lactate clearance | Canada Hyperbarics Skip to main content
Retrospective Study Open Med (Wars) 2026

Optimizing hyperbaric oxygen initiation time in carbon monoxide poisoning: a 3-hour window enhances neurological recovery via lactate clearance

Xu D, Xu X, Sun H, Xu J, Fei D, Shen Y — Open Med (Wars), 2026

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers studied 12 patients with moderate-to-severe carbon monoxide poisoning to see if starting hyperbaric oxygen therapy earlier improved their recovery and to assess the value of lactate clearance and early MRI findings.

What They Found

Patients who received HBOT within 3 hours showed faster organ function recovery. Lactate levels normalizing within a median of 17.5 hours and clearing over 50% in 24 hours were linked to better neurological outcomes. Overall, 83.3% of patients recovered functionally after six months.

What This Means for Canadian Patients

For Canadian patients experiencing moderate-to-severe carbon monoxide poisoning, these findings suggest that receiving hyperbaric oxygen therapy as soon as possible, ideally within three hours, could lead to better metabolic and neurological recovery. Early monitoring of lactate levels and MRI scans may also help predict how well a patient will recover.

Canadian Relevance

This study covers carbon monoxide poisoning, which is a Health Canada-recognized indication for hyperbaric oxygen therapy.

Study Limitations

The study's small sample size of 12 patients and lack of a control group mean the results are preliminary and need further confirmation.

Was this summary helpful?

Study Details

Study Type Retrospective Study
Category Neurological
Source Pubmed
PubMed ID 41726145
Year Published 2026
Journal Open Med (Wars)

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.